Neurocrine Biosciences Inc vs Open Text Corporation — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Open Text Corporation trades at $22.77 (market cap $5.61B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.1× Open Text Corporation's market cap, and Open Text Corporation pays a 4.72% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | OTEX | |
|---|---|---|
Market Cap | $17.40B | $5.61B |
Sector | Health | Technology |
52-Week High | $180.55 | $39.69 |
52-Week Low | $123.10 | $20.01 |
Enterprise Value | $16.49B | $10.77B |
Dividend Yield | — | 4.72% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →